Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurotoxic and Nephrotoxic Effects of Colistin in Patients with Renal Disease
Emanuel Wolinsky, John Hines
New England Journal of Medicine (1962) Vol. 266, Iss. 15, pp. 759-762
Closed Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li, Roger L. Nation, John Turnidge, et al.
The Lancet Infectious Diseases (2006) Vol. 6, Iss. 9, pp. 589-601
Closed Access | Times Cited: 1336
Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii
Anna S. Levin, Antonio Barone, Juliana Penço, et al.
Clinical Infectious Diseases (1999) Vol. 28, Iss. 5, pp. 1008-1011
Open Access | Times Cited: 620
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Jian Li, Roger L. Nation, Robert Milne, et al.
International Journal of Antimicrobial Agents (2004) Vol. 25, Iss. 1, pp. 11-25
Closed Access | Times Cited: 553
Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative Bacteria
Martin E. Evans, David J. Feola, Robert P. Rapp
Annals of Pharmacotherapy (1999) Vol. 33, Iss. 9, pp. 960-967
Closed Access | Times Cited: 551
Colistin: an update on the antibiotic of the 21st century
Silpak Biswas, Jean Michel Brunel, J.‐C. Dubus, et al.
Expert Review of Anti-infective Therapy (2012) Vol. 10, Iss. 8, pp. 917-934
Closed Access | Times Cited: 542
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings
Wenjing Wu, Yu Feng, Guangmin Tang, et al.
Clinical Microbiology Reviews (2019) Vol. 32, Iss. 2
Open Access | Times Cited: 522
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Charles H. Chen, Timothy K. Lu
Antibiotics (2020) Vol. 9, Iss. 1, pp. 24-24
Open Access | Times Cited: 490
Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP
José Garnacho‐Montero, Carlos Ortíz-Leyba, F. J. Jiménez-Jiménez, et al.
Clinical Infectious Diseases (2003) Vol. 36, Iss. 9, pp. 1111-1118
Open Access | Times Cited: 476
Adverse Effects of Sodium Colistimethate
Jan Koch‐Weser
Annals of Internal Medicine (1970) Vol. 72, Iss. 6, pp. 857-857
Closed Access | Times Cited: 436
Neurotoxic effects associated with antibiotic use: management considerations
Marie Grill, Rama Maganti
British Journal of Clinical Pharmacology (2011) Vol. 72, Iss. 3, pp. 381-393
Open Access | Times Cited: 359
Antimicrobial peptides for combating drug-resistant bacterial infections
Jiaqi Xuan, Weiguo Feng, Jiaye Wang, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100954-100954
Open Access | Times Cited: 323
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Sue C. Nang, Mohammad Abul Kalam Azad, Tony Velkov, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 679-728
Open Access | Times Cited: 290
Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa
Peter K. Linden, Shimon Kusne, Kim C. Coley, et al.
Clinical Infectious Diseases (2003) Vol. 37, Iss. 11, pp. e154-e160
Closed Access | Times Cited: 261
The Neurotoxicity of Antibacterial Agents
Sharon R. Snavely
Annals of Internal Medicine (1984) Vol. 101, Iss. 1, pp. 92-92
Closed Access | Times Cited: 241
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study
Rosa Reina, Elisa Estenssoro, Gabriela Sáenz, et al.
Intensive Care Medicine (2005) Vol. 31, Iss. 8, pp. 1058-1065
Open Access | Times Cited: 189
Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative Bacteria
John P. Ouderkirk, Jill A. Nord, Glenn Turett, et al.
Antimicrobial Agents and Chemotherapy (2003) Vol. 47, Iss. 8, pp. 2659-2662
Open Access | Times Cited: 188
Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa
Qin Lü, Cassio Girardi, Mao Zhang, et al.
Intensive Care Medicine (2010) Vol. 36, Iss. 7, pp. 1147-1155
Open Access | Times Cited: 172
Role of Oxidative Stress in Drug-Induced Kidney Injury
Keiko Hosohata
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 11, pp. 1826-1826
Open Access | Times Cited: 164
What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
Diana F. Florescu, Fang Qiu, Megan A. McCartan, et al.
Clinical Infectious Diseases (2012) Vol. 54, Iss. 5, pp. 670-680
Open Access | Times Cited: 146
Toxic nephropathy
George E. Schreiner, John Maher
The American Journal of Medicine (1965) Vol. 38, Iss. 3, pp. 409-449
Closed Access | Times Cited: 118
Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step Toward Pragmatism in Benefit:Risk Evaluation
Scott Evans, Dean Follmann
Statistics in Biopharmaceutical Research (2016) Vol. 8, Iss. 4, pp. 386-393
Open Access | Times Cited: 113
Adverse Reactions Associated with Systemic Polymyxin Therapy
Julie Ann Justo, John A. Bosso
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2014) Vol. 35, Iss. 1, pp. 28-33
Closed Access | Times Cited: 112
The safety of polymyxin antibiotics
Theodoros Kelesidis, Matthew E. Falagas
Expert Opinion on Drug Safety (2015) Vol. 14, Iss. 11, pp. 1687-1701
Open Access | Times Cited: 99
Use of High-Performance Liquid Chromatography To Study the Pharmacokinetics of Colistin Sulfate in Rats following Intravenous Administration
Jian Li, Robert Milne, Roger L. Nation, et al.
Antimicrobial Agents and Chemotherapy (2003) Vol. 47, Iss. 5, pp. 1766-1770
Open Access | Times Cited: 160
The Pharmacokinetics of Colistin in Patients with Cystic Fibrosis
Michael D. Reed, Robert C. Stern, Mary Ann O’Riordan, et al.
The Journal of Clinical Pharmacology (2001) Vol. 41, Iss. 6, pp. 645-654
Closed Access | Times Cited: 152
Page 1 - Next Page

Scroll to top